Outcomes of antiviral treatment in hepatitis C virus liver transplant patients off immunosuppression in the direct acting antivirals era: A case series

Clinical Transplantation
Isabel Campos-VarelaNorah A Terrault

Abstract

Clearance of hepatitis C virus (HCV) under antiviral therapy, including direct-acting antivirals (DAAs), has been associated with higher risk of rejection. Whether patients who are not on immunosuppression (IS) during DAA therapy are at higher risk of rejection is unknown. Four transplant recipients who were off IS and treated with DAA therapy were identified. All patients were genotype 1 infection and treated for 12 weeks with sofosbuvir/ledipasvir/ribavirin. At the time of DAA therapy, patients were off IS for a median of 9.5 years. Time from liver transplant (LT) to treatment was 12.9 years. Median baseline ALT was 70 IU/L, at follow-up week 12 was 18 IU/L. No signs of rejection were observed during DAA therapy or follow-up after the end of therapy. All 4 patients obtained sustained virological response. Direct-acting antivirals therapy in HCV patients off IS post-LT can be successfully undertaken without the need to restart IS.

References

May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Johnson Y N LauZhi Hong
Oct 31, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Marcelo KugelmasGregory T Everson
Feb 26, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M BerenguerM Prieto
Oct 1, 2008·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Edward J Gane
May 31, 2012·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·UNKNOWN Banff Working Group on Liver Allograft Pathology
Oct 20, 2012·Expert Review of Clinical Immunology·Tommaso Maria ManziaGiuseppe Tisone
Jan 3, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Tommaso Maria ManziaGiuseppe Tisone
Mar 28, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Carlos BenítezAlberto Sánchez-Fueyo
Jun 7, 2014·Journal of Hepatology·Bianca MartinRobert Thimme
Nov 12, 2014·The New England Journal of Medicine·Paul Y KwoXavier Forns
Jan 6, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xavier FornsFrançois Habersetzer
Nov 1, 2015·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Robert S BrownUNKNOWN HCV-TARGET Study Group
Nov 26, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·R TaubertE Jaeckel
Jan 17, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Satoru TodoKo Okumura
Mar 2, 2016·Current Opinion in Organ Transplantation·Tianyan Chen, Norah A Terrault
Oct 30, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Josh LevitskyAbraham Shaked
Feb 9, 2017·Cellular and Molecular Gastroenterology and Hepatology·David S CampoYury Khudyakov
May 16, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Varun SaxenaK Rajender Reddy
Oct 22, 2017·Human Immunology·Josh Levitsky, Sandy Feng

❮ Previous
Next ❯

Citations

Nov 13, 2018·Journal of Korean Medical Science·Durga Prasanna MisraVikas Agarwal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
N R Hussein, Z S M Saleem
Transplant International : Official Journal of the European Society for Organ Transplantation
E De MartinAnne-Marie Roque-Afonso
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Julio A GutierrezAdam Peyton
© 2022 Meta ULC. All rights reserved